Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: SQM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on SQM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 119 SQM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 119 shares
    Change vs previous 13F -63 shares

    <0.01% of the 13F portfolio, value $8,811.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 182 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $14,731.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 182 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $12,523.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 182 shares
    Change vs previous 13F -49 shares

    <0.01% of the 13F portfolio, value $7,823.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 231 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $8,148.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).